Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Glioma Treatment Market Size And Revenue Outlook Through 2030
The glioma treatment market size has shown significant expansion in recent years. It is projected to increase from $5.37 billion in 2025 to $5.72 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.4%. The growth observed in prior periods can be attributed to advances in neurosurgery, the proliferation of radiation oncology, the uptake of chemotherapy, enhanced diagnostic imaging, and the expansion of cancer care facilities.
The glioma treatment market is anticipated to experience robust expansion in the coming years, with its size projected to reach $7.44 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8%. This projected increase in the forecast period stems from the integration of precision oncology, the development of novel targeted drugs, an enhanced focus on improving survival outcomes, the expansion of specialty oncology clinics, and the implementation of personalized treatment protocols. Significant trends expected during this period encompass a rise in the use of combination therapy approaches, an increased emphasis on early surgical intervention, the expansion of targeted drug therapies, the growing importance of radiation therapy optimization, and improved long-term disease management strategies.
Get A Free Sample Report With In-Depth Market Insights:
Glioma Treatment Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing demand for personalized medicine is anticipated to propel the growth of the glioma treatment market going forward. Personalized medicine refers to a tailored healthcare approach that considers individual patient characteristics, including genetics, environment, and lifestyle, to improve treatment effectiveness and outcomes. This rising demand for personalized medicine is driven by various factors, such as advancements in genomics, patient empowerment, and enhanced treatment efficacy. The identification of biomarkers associated with gliomas helps forecast treatment responses and outcomes, enabling the creation of personalized treatment plans customized to each patient’s specific attributes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Consequently, the growing demand for personalized medicine drives the growth of the glioma treatment market.
Glioma Treatment Market Segmentation: How Does The Market Break Down By Category?
The glioma treatment market covered in this report is segmented –
1) By Type: Low-Grade, High-Grade
2) By Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Other Treatments
5) By End-User: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Low-Grade: Astrocytoma, Oligodendroglioma, Mixed Glioma
2) By High-Grade: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma
Glioma Treatment Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the glioma treatment market are increasingly incorporating innovative products like immunotherapies to enhance patient outcomes and improve tumor targeting efficiency. Immunotherapies work by stimulating or leveraging the body’s immune system to recognize and attack malignant cells. For example, in June 2024, Servier Pharmaceuticals, a France-based pharmaceutical company, obtained FDA approval for VORANIGO (vorasidenib) tablets, an important landmark as the first targeted therapy for Grade 2 IDH-mutant glioma. Vorasidenib is a dual inhibitor designed to target isocitrate dehydrogenase (IDH) 1 and 2 mutations, frequently observed in gliomas. These mutations cause the production of 2-hydroxyglutarate (2-HG), a metabolite that encourages tumor growth and survival. By inhibiting these enzymes, vorasidenib decreases 2-HG levels, thereby potentially impeding tumor progression.
Glioma Treatment Market Competitive Overview And Top Companies
Major companies operating in the glioma treatment market are Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Emcure Pharmaceuticals Ltd., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., Agios Pharmaceuticals Inc.
View The Full Glioma Treatment Market Report:
Glioma Treatment Market Top Region By Revenue And Market Share
North America was the largest region in the glioma treatment market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global glioma treatment market report during the forecast period. The regions covered in the glioma treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
